---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-059362"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:58:43.021627+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# TransCode sets 2025 annual meeting Aug 29; proposal deadline June 23

## Summary
- 2025 Annual Meeting scheduled for August 29, 2025; record date July 11, 2025.
- Stockholder proposals under Rule 14a-8 must be submitted by close of business on June 23, 2025.
- Director nominations and other business also due by June 23, 2025 under universal proxy rules.
- Meeting date is more than 30 days from June 13, 2024 annual meeting, triggering adjusted deadlines.

## SEC filing metadata
- accession: 0001104659-25-059362
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465925059362/0001104659-25-059362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465925059362/tm2517990d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-059362
- JSON: https://secwatch.observer/filing/0001104659-25-059362.json
- Plain text: https://secwatch.observer/filing/0001104659-25-059362.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.